Takara Bio USA

Takara Bio USA

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Takara Bio USA, founded in 1999 and headquartered in San Jose, California, is a leading provider of research tools and services in the life sciences sector. The company specializes in developing innovative products for spatial biology, single-cell genomics, and NGS library preparation, leveraging strategic partnerships with firms like Illumina and Hamilton Company to automate and integrate workflows. While primarily a tools and services platform rather than a therapeutic developer, it plays a critical enabling role in the genetics, genomics, and therapy research markets by supplying high-quality reagents and customized enzyme services to accelerate scientific discovery.

Genetics & GenomicsCell TherapyGene Therapy

Technology Platform

Portfolio of integrated platforms for spatial biology (Trekker), single-cell analysis (Shasta), and NGS library prep, plus a custom enzyme service for assay development.

Opportunities

The rapid growth in spatial biology and single-cell analysis presents a major opportunity for its Trekker and Shasta platforms.
Partnerships with automation (Hamilton) and sequencing (Illumina) leaders position it to capture demand for integrated, standardized workflows in both research and clinical labs.

Risk Factors

Faces intense competition from larger life science tools companies.
Technological disruption in spatial genomics or sequencing could threaten its integrated product strategy.
Reliance on key partners like Illumina creates ecosystem dependency risks.

Competitive Landscape

Operates in the highly competitive life sciences research tools market, competing with giants like Thermo Fisher Scientific, 10x Genomics, Bio-Rad, and Qiagen. Differentiates through specialized spatial biology innovations, custom enzyme services, and strategic automation partnerships.